NED416, a novel synthetic Sirt1 activator, promotes cutaneous wound healing via the MAPK/Rho pathway.

Int J Mol Med · 2020 · PMC7255464 · PMID 32319533

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

Although the effect of NED416 was only significant at 10 μ M, a notable trend towards increased angiogenesis was also observed in 5 μ M-treated cells ( Fig. 4F ).

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.